Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028: GlobalData Read more
Opportunities for cell and gene therapy landscape remain high but so does challenges: GlobalData Read more
High ADHD comorbidity rates offer opportunity for pipeline products to capture market: GlobalData Read more
FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two years: GlobalData Read more